Numerate

About:

Numerate seeks to overcome major challenges in drug discovery by applying novel machine-learning algorithms, at cloud scale, to drug design.

Website: http://www.numerate.com

Twitter/X: Numerate_Inc

Top Investors: Foundation Capital, National Heart, Lung and Blood Institute, Lilly Ventures, Atlas Venture, Lanza Tech Ventures

Description:

Numerate is a group of cutting-edge scientists and engineers trying to solve very difficult problems at the interface of data science, machine learning, cloud scale analytics and medicinal chemistry. We have developed a computational platform that can predict how a potential drug will behave in the lab and the body. We use this platform to process large spaces of chemistry while searching for therapies for some of the world’s most important diseases, such as, obesity, heart failure, Alzheimer’s, and Huntington’s disease. Our platform makes the drug development process cheaper, faster, and results in higher success rates than traditional approaches.